Vasoconstriction to endogenous endothelin-1 is impaired in patients with type II diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical science

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/CS20000005PMID 11787468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered endothelin-1 induced contraction and second messenger generation in bovine retinal microvascular pericytes cultured in high glucose medium

  2004cited by this paper
• Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure.

  1996cited by this paper
• Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ETA receptor blockade in chronic heart failure patients treated with ACE inhibitors.

  1996cited by this paper
• Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.

  1996cited by this paper
• Enhanced Coronary Vasoconstriction to Endothelin-BReceptor Activation in Experimental Congestive Heart Failure

  1996cited by this paper
• Impaired Vasoconstriction to Endothelin 1 in Patients With NIDDM

  1996cited by this paper
• Molecular Characterization of Endothelin Receptors and the Effect of Insulin on Their Expression in Retinal Microvascular Pericytes

  1995cited by this paper
• Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

  1995cited by this paper
• The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats.

  1995cited by this paper
• Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo.

  1995cited by this paper
• Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo.

  1995cited by this paper
• Contribution of endogenous generation of endothelin-1 to basal vascular tone.

  1994cited by this paper
• Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

  1994cited by this paper
• Endothelin in human congestive heart failure.

  1994cited by this paper
• Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus.

  1994cited by this paper
• Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus

  1993cited by this paper
• Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin‐1 of aortic rings from streptozotocin‐induced diabetic rats

  1992cited by this paper
• Increased plasma concentrations of endothelin in congestive heart failure in humans.

  1992cited by this paper
• Increased Plasma Endothelin in NIDDM Patients With Retinopathy

  1992cited by this paper
• Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

  1992cited by this paper
• Attenuated responses to endothelin‐1, KCl and CaCl2, but not noradrenaline, of aortae from rats with streptozotocin‐induced diabetes mellitus

  1991cited by this paper
• Plasma endothelin-1 levels in patients with diabetes mellitus with or without vascular complication.

  1991cited by this paper
• Vascular responsiveness and cation exchange in insulin-dependent diabetes.

  1991cited by this paper
• Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

  1991cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• Analysis of serial measurements in medical research.

  1990cited by this paper
• Increased plasma endothelin level in patients with essential hypertension.

  1990cited by this paper
• Elevated plasma endothelin in patients with diabetes mellitus

  1990cited by this paper
• Vascular Reactivity to Angiotensin II and to Norepinephrine in Diabetic Subjects

  1976cited by this paper

• Pulse wave amplitude drops during sleep: clinical significance and characteristics in a general population sample

  2020cites this paper
• DIABETES MELLITUS AND PULMONARY CIRCULATION (PART 2)

  2019cites this paper
• Endothelial dysfunction and vascular disease – a 30th anniversary update

  2017cites this paper
• Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy

  2017cites this paper
• The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus

  2015cites this paper
• In-vivo Biomarkers for Detection of Early Diabetic Retinopathy Using Aqueous Humor Cytokines and Functional Retinal Imaging Techniques

  2015cites this paper
• Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

  2014cites this paper
• Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes.

  2012cites this paper
• Hemodynamic and metabolic actions of Adiponectin in muscle

  2011cites this paper
• The effects of resistance training on individuals with clusters of metabolic risk factors : focus on functional capacities, clinical outcomes and quality of life

  2008cites this paper
• Endothelin-1 Vasoconstrictor Tone Increases With Age in Healthy Men But Can Be Reduced by Regular Aerobic Exercise

  2007cites this paper
• Acute blockade by endothelin-1 of haemodynamic insulin action in rats

  2007cites this paper
• Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide.

  2007cites this paper
• Impaired endothelin-induced vasoconstriction in coronary arteries of Zucker obese rats is associated with uncoupling of [Ca2+]i signaling.

  2006cites this paper
• Contribution of endothelin receptors and cyclooxygenase-derivatives to the altered response of the rabbit renal artery to endothelin-1 in diabetes.

  2006cites this paper
• Impaired effect of endothelin-1 on coronary artery stiffness in type 2 diabetes.

  2006cites this paper
• Coronary vascular dysfunction in obese type 2 diabetic mice.

  2006cites this paper
• Vascular dysfunction and obesity

  2006cites this paper
• Retinal Blood Flow and Vascular Reactivity in Diabetic Retinopathy

  2006cites this paper
• Influencia de la diabetes experimental sobre la reactividad de las arterias basilar, carótida y renal de conejo a la endotelina-1.

  2006cites this paper
• Metabolic Syndrome Impaired endothelin-induced vasoconstriction in coronary arteries of Zucker obese rats is associated with uncoupling of [ Ca 2 ] i signaling

  2005cites this paper
• Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.

  2004cites this paper
• Alteration in endothelin receptor sub-type responsiveness and in the endothelin-TXA(2) mimetic U46619 interaction, in type-2 hypertensive diabetic Zucker rats.

  2004cites this paper
• Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type‐2 diabetes: studies in gonadectomized and sham‐operated Zucker diabetic rats

  2004cites this paper
• Blood flow and muscle metabolism: a focus on insulin action.

  2003cites this paper
• Endothelin-1 and Vascular Tone in Subjects With Atherogenic Risk Factors

  2003cites this paper
• Challenges in oral therapy for erectile dysfunction.

  2002cites this paper
• Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes.

  2002cites this paper
• Perioperative risk factors for posterior ischemic optic neuropathy.

  2002cites this paper
• Endothelin antagonism: physiology or pharmacology?

  2002cites this paper
• The therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system

  2002cites this paper
• Insulin Action in the Vasculature: Physiology and Pathophysiology

  2001cites this paper
• ReviewChallenges in Oral Therapy for Erectile Dysfunction

  year unknowncites this paper